Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest in USD of BIO-TECHNE Corp from Q2 2018 to Q3 2025

Taxonomy & unit
us-gaap: USD
Description
Amount of stockholders' equity (deficit), net of receivables from officers, directors, owners, and affiliates of the entity, attributable to both the parent and noncontrolling interests. Amount excludes temporary equity. Alternate caption for the concept is permanent equity.
Summary
BIO-TECHNE Corp quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest history and change rate from Q2 2018 to Q3 2025.
  • BIO-TECHNE Corp Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest for the quarter ending September 30, 2025 was $1.97B, a 8.08% decline year-over-year.
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, Quarterly (USD)
Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest, YoY Quarterly Change (%)

BIO-TECHNE Corp Quarterly Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest (USD)

Period Value YoY Chg Change % Date Report Filed
Q3 2025 $1.97B -$173M -8.08% Sep 30, 2025 10-Q 2025-11-05
Q2 2025 $1.92B -$150M -7.25% Jun 30, 2025 10-Q 2025-11-05
Q3 2024 $2.14B +$141M +7.05% Sep 30, 2024 10-Q 2025-11-05
Q2 2024 $2.07B +$102M +5.2% Jun 30, 2024 10-Q 2025-11-05
Q1 2024 $2.01B +$125M +6.6% Mar 31, 2024 10-Q 2024-05-06
Q4 2023 $1.96B +$136M +7.47% Dec 31, 2023 10-Q 2024-05-06
Q3 2023 $2B +$247M +14.1% Sep 30, 2023 10-Q 2024-11-05
Q2 2023 $1.97B +$266M +15.6% Jun 30, 2023 10-K 2025-08-22
Q1 2023 $1.89B +$176M +10.3% Mar 31, 2023 10-Q 2024-05-06
Q4 2022 $1.83B +$125M +7.32% Dec 31, 2022 10-Q 2024-05-06
Q3 2022 $1.75B +$104M +6.33% Sep 30, 2022 10-Q 2024-05-06
Q2 2022 $1.7B +$130M +8.26% Jun 30, 2022 10-K 2025-08-22
Q1 2022 $1.71B +$165M +10.7% Mar 31, 2022 10-Q 2023-05-08
Q4 2021 $1.7B +$172M +11.2% Dec 31, 2021 10-Q 2023-05-08
Q3 2021 $1.65B +$208M +14.4% Sep 30, 2021 10-Q 2023-05-08
Q2 2021 $1.57B +$190M +13.8% Jun 30, 2021 10-K 2024-08-22
Q1 2021 $1.55B +$257M +19.9% Mar 31, 2021 10-Q 2022-05-09
Q4 2020 $1.53B +$208M +15.7% Dec 31, 2020 10-Q 2022-05-09
Q3 2020 $1.44B +$265M +22.6% Sep 30, 2020 10-Q 2022-05-09
Q2 2020 $1.38B +$216M +18.5% Jun 30, 2020 10-K 2023-08-23
Q1 2020 $1.29B Mar 31, 2020 10-Q 2021-05-07
Q4 2019 $1.32B Dec 31, 2019 10-Q 2021-05-07
Q3 2019 $1.17B Sep 30, 2019 10-Q 2021-05-07
Q2 2019 $1.17B +$86.5M +8.02% Jun 30, 2019 10-K 2022-08-24
Q2 2018 $1.08B Jun 30, 2018 10-K 2021-08-25
* An asterisk sign (*) next to the value indicates that the value is likely invalid.